Results 91 to 100 of about 17,080,419 (148)

Transcriptional regulation of proto-oncogene c-myc by MAZ(Myc-associated zinc finger protein)

, 2000
openaire   +1 more source

Multifaceted regulatory role of proline‑ and glutamine-rich splicing factor in tumors (Review). [PDF]

Mol Med Rep
Zhang S, Li Z, Fu L.
europepmc   +1 more source

miR-17: from developmental regulatory hub to molecular engine driving tumourigenesis. [PDF]

Front Oncol
Zhang M, Ma YR, Chen XY, Sun TS, Wang XY, Wang BB, Wang FH.   +6 more
europepmc   +1 more source

Sustained MYC overexpression drives myeloid differentiation block and acquisition of leukemic phenotypes. [PDF]

Exp Hematol
Stokes N, Carcamo S, Demircioglu D, Wang X, Olszewska M, Hasson D, Watanabe H, Papapetrou EP, Dominguez-Sola D.   +8 more
europepmc   +1 more source

Analysis of c-MYC-induced chromosomal instability and generation of a conditional microRNA expression system [PDF]

, 2008
Epanchintsev, Alexey
core   +1 more source

A novel mechanism by which c-MYC is aberrantly activated by epigenetic silencing of its antisense lncRNA in colon cancer. [PDF]

Front Genet
Hu X, Wei Y, Zhang M, Dou C, Wang L, Zaib G, Wu H, Guo W, Wang X, Chen S, Xu Q, Guo M, Cui H.   +12 more
europepmc   +1 more source

LncRNA-LINC01281 exerts anti-cancer functions via the MYC/VEGF pathway in the progression of cervical cancer. [PDF]

J Cancer Res Clin Oncol
Shuqian Z, Zhi C, Ain Q, Yan L, Chengfang L, Xiaoxu B, Song Z, Jiayin G.   +7 more
europepmc   +1 more source

G3BP1 is a SWI/SNF-bound regulator of transcription that modulates activation of STATs. [PDF]

Biosci Rep
Papadopoulos N, Sarri N, Lennartsson J, Heldin CH.   +3 more
europepmc   +1 more source

Heterobifunctional proteomimetic polymers for targeted degradation of MYC and KRAS. [PDF]

Nat Commun
Wang MM, Truica MI, Gattis BS, Oktawiec J, Sagar V, Basu AA, Bertin PA, Zhang X, Abdulkadir SA, Gianneschi NC.   +9 more
europepmc   +1 more source

Dynamic, anthracycline-induced chromatin alterations enable ALDH1 expression as a mechanism of inducible leukemia resistance development. [PDF]

Blood Res
Vlahopoulos SA.
europepmc   +1 more source